Cargando…
FGF21 alleviates pulmonary hypertension by inhibiting mTORC1/EIF4EBP1 pathway via H19
Long non‐coding RNAs (lncRNAs) play a significant role in pulmonary hypertension (PH). Our preliminary data showed that hypoxia‐induced PH is attenuated by fibroblast growth factor 21 (FGF21) administration. Therefore, we further investigated the regulatory role of long non‐coding RNAs in PH treated...
Autores principales: | Li, Xiuchun, Zhang, Yaxin, Su, Lihuang, Cai, Luqiong, Zhang, Chi, Zhang, Jianhao, Sun, Junwei, Chai, Mengyu, Cai, Mengsi, Wu, Qian, Yan, Xiaoqing, Wang, Liangxing, Huang, Xiaoying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9097832/ https://www.ncbi.nlm.nih.gov/pubmed/35437883 http://dx.doi.org/10.1111/jcmm.17318 |
Ejemplares similares
-
FGF21 attenuates pulmonary arterial hypertension via downregulation of miR‐130, which targets PPARγ
por: Wang, Meibin, et al.
Publicado: (2022) -
FGF21 attenuates hypoxia-induced dysfunction and inflammation in HPAECs via the microRNA-27b-mediated PPARγ pathway
por: Yao, Dan, et al.
Publicado: (2021) -
mTORC1 and CK2 coordinate ternary and eIF4F complex assembly
por: Gandin, Valentina, et al.
Publicado: (2016) -
Pathogenic Role of mTORC1 and mTORC2 in Pulmonary Hypertension
por: Tang, Haiyang, et al.
Publicado: (2018) -
Integrated bioinformatic analysis reveals the underlying molecular mechanism of and potential drugs for pulmonary arterial hypertension
por: Dong, Haoru, et al.
Publicado: (2021)